These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1406 related items for PubMed ID: 28460563

  • 21. [Melatonin for the regulation of sleep and other biological rhythms].
    Zhdanova IV, Poluectov MG.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(5. Vyp. 2):8-13. PubMed ID: 38934660
    [Abstract] [Full Text] [Related]

  • 22. Day/night melatonin content in cerebral palsy.
    Santos JS, Giacheti CM, Dornelas LS, Silva NC, Souza ALDM, Guissoni Campos LM, Pinato L.
    Neurosci Lett; 2018 Nov 01; 686():23-27. PubMed ID: 30176339
    [Abstract] [Full Text] [Related]

  • 23. Melatonin in sleep disorders.
    Poza JJ, Pujol M, Ortega-Albás JJ, Romero O, en representación del Grupo de estudio de insomnio de la Sociedad Española de Sueño (SES).
    Neurologia (Engl Ed); 2022 Sep 01; 37(7):575-585. PubMed ID: 30466801
    [Abstract] [Full Text] [Related]

  • 24. The use of prolonged-release melatonin in circadian medicine: a systematic review.
    Del Casale A, Arena JF, Giannetti F, Minervino A, Biggio G, Girardi P.
    Minerva Med; 2024 Apr 01; 115(2):125-142. PubMed ID: 38713204
    [Abstract] [Full Text] [Related]

  • 25. New perspectives for the treatment of disorders of sleep and arousal.
    Sanger DJ, Soubrane C, Scatton B.
    Ann Pharm Fr; 2007 Jul 01; 65(4):268-74. PubMed ID: 17652996
    [Abstract] [Full Text] [Related]

  • 26. MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.
    Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M, Dubocovich ML.
    Annu Rev Pharmacol Toxicol; 2016 Jul 01; 56():361-83. PubMed ID: 26514204
    [Abstract] [Full Text] [Related]

  • 27. Melatonin: aeromedical, toxicopharmacological, and analytical aspects.
    Sanders DC, Chaturvedi AK, Hordinsky JR.
    J Anal Toxicol; 1999 Jul 01; 23(3):159-67. PubMed ID: 10369324
    [Abstract] [Full Text] [Related]

  • 28. Melatonin and circadian rhythms in autism: Case report.
    Zuculo GM, Gonçalves BSB, Brittes C, Menna-Barreto L, Pinato L.
    Chronobiol Int; 2017 Jul 01; 34(4):527-530. PubMed ID: 28426389
    [Abstract] [Full Text] [Related]

  • 29. Melatonin in autism spectrum disorders.
    Rossignol DA, Frye RE.
    Curr Clin Pharmacol; 2014 Jul 01; 9(4):326-34. PubMed ID: 24050742
    [Abstract] [Full Text] [Related]

  • 30. Intrinsic circadian period of sighted patients with circadian rhythm sleep disorder, free-running type.
    Kitamura S, Hida A, Enomoto M, Watanabe M, Katayose Y, Nozaki K, Aritake S, Higuchi S, Moriguchi Y, Kamei Y, Mishima K.
    Biol Psychiatry; 2013 Jan 01; 73(1):63-9. PubMed ID: 22846439
    [Abstract] [Full Text] [Related]

  • 31. Can the circadian phase be estimated from self-reported sleep timing in patients with Delayed Sleep Wake Phase Disorder to guide timing of chronobiologic treatment?
    Lovato N, Micic G, Gradisar M, Ferguson SA, Burgess HJ, Kennaway DJ, Lack L.
    Chronobiol Int; 2016 Jan 01; 33(10):1376-1390. PubMed ID: 27611743
    [Abstract] [Full Text] [Related]

  • 32. Melatonin for primary insomnia?
    Drug Ther Bull; 2009 Jul 01; 47(7):74-7. PubMed ID: 19567841
    [Abstract] [Full Text] [Related]

  • 33. Daily melatonin intake resets circadian rhythms of a sighted man with non-24-hour sleep-wake syndrome who lacks the nocturnal melatonin rise.
    Nakamura K, Hashimoto S, Honma S, Honma K.
    Psychiatry Clin Neurosci; 1997 Jun 01; 51(3):121-7. PubMed ID: 9225375
    [Abstract] [Full Text] [Related]

  • 34. Melatonin--the key to the gate of sleep.
    Shochat T, Haimov I, Lavie P.
    Ann Med; 1998 Feb 01; 30(1):109-14. PubMed ID: 9556097
    [Abstract] [Full Text] [Related]

  • 35. Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine.
    Pandi-Perumal SR, Moscovitch A, Srinivasan V, Spence DW, Cardinali DP, Brown GM.
    Prog Neurobiol; 2009 Aug 01; 88(4):264-71. PubMed ID: 19454302
    [Abstract] [Full Text] [Related]

  • 36. Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults.
    Tuft C, Matar E, Menczel Schrire Z, Grunstein RR, Yee BJ, Hoyos CM.
    Clin Interv Aging; 2023 Aug 01; 18():49-59. PubMed ID: 36660543
    [Abstract] [Full Text] [Related]

  • 37. Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders.
    Williams WP, McLin DE, Dressman MA, Neubauer DN.
    Pharmacotherapy; 2016 Sep 01; 36(9):1028-41. PubMed ID: 27500861
    [Abstract] [Full Text] [Related]

  • 38. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
    Srinivasan V, Pandi-Perumal SR, Trahkt I, Spence DW, Poeggeler B, Hardeland R, Cardinali DP.
    Int J Neurosci; 2009 Sep 01; 119(6):821-46. PubMed ID: 19326288
    [Abstract] [Full Text] [Related]

  • 39. The use and misuse of exogenous melatonin in the treatment of sleep disorders.
    Riha RL.
    Curr Opin Pulm Med; 2018 Nov 01; 24(6):543-548. PubMed ID: 30148726
    [Abstract] [Full Text] [Related]

  • 40. Melatonin in sleep disorders.
    Poza JJ, Pujol M, Ortega-Albás JJ, Romero O, Insomnia Study Group of the Spanish Sleep Society (SES).
    Neurologia (Engl Ed); 2022 Sep 01; 37(7):575-585. PubMed ID: 36064286
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 71.